| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Methylation | 23 | 2021 | 138 | 4.160 |
Why?
|
| Arthritis, Rheumatoid | 11 | 2019 | 232 | 2.330 |
Why?
|
| CpG Islands | 13 | 2015 | 46 | 2.100 |
Why?
|
| Epigenesis, Genetic | 7 | 2021 | 71 | 1.710 |
Why?
|
| Autoimmune Diseases | 4 | 2019 | 40 | 1.360 |
Why?
|
| Repressor Proteins | 6 | 2018 | 29 | 1.190 |
Why?
|
| Lung Neoplasms | 6 | 2011 | 470 | 1.130 |
Why?
|
| Arthritis, Experimental | 3 | 2019 | 33 | 1.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2011 | 105 | 0.890 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2011 | 46 | 0.820 |
Why?
|
| B-Lymphocytes | 5 | 2019 | 40 | 0.730 |
Why?
|
| DNA | 7 | 2010 | 86 | 0.730 |
Why?
|
| Animals | 20 | 2021 | 3025 | 0.730 |
Why?
|
| Azacitidine | 2 | 2021 | 8 | 0.680 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 215 | 0.660 |
Why?
|
| Enzyme Inhibitors | 1 | 2019 | 92 | 0.620 |
Why?
|
| Genetic Techniques | 2 | 2010 | 3 | 0.610 |
Why?
|
| Receptors, Interleukin-1 Type II | 1 | 2018 | 1 | 0.610 |
Why?
|
| DNA-Binding Proteins | 5 | 2021 | 227 | 0.600 |
Why?
|
| Disease Models, Animal | 7 | 2019 | 477 | 0.600 |
Why?
|
| Promoter Regions, Genetic | 10 | 2021 | 72 | 0.580 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2016 | 1 | 0.520 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2016 | 4 | 0.510 |
Why?
|
| Mice | 12 | 2021 | 1128 | 0.510 |
Why?
|
| Myocarditis | 1 | 2016 | 8 | 0.510 |
Why?
|
| Heart | 1 | 2016 | 43 | 0.500 |
Why?
|
| Biomarkers, Tumor | 3 | 2011 | 165 | 0.480 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 99 | 0.480 |
Why?
|
| Genome, Human | 4 | 2015 | 37 | 0.460 |
Why?
|
| Humans | 31 | 2023 | 22848 | 0.460 |
Why?
|
| Mice, Inbred BALB C | 5 | 2018 | 70 | 0.450 |
Why?
|
| Chromosome Mapping | 3 | 2009 | 26 | 0.430 |
Why?
|
| Neoplasms | 4 | 2011 | 205 | 0.410 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2011 | 155 | 0.360 |
Why?
|
| Chromatin | 4 | 2014 | 16 | 0.360 |
Why?
|
| Cell Differentiation | 3 | 2010 | 111 | 0.340 |
Why?
|
| Blotting, Western | 4 | 2016 | 130 | 0.330 |
Why?
|
| Mutation | 5 | 2023 | 284 | 0.330 |
Why?
|
| Cell Line | 6 | 2021 | 222 | 0.310 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2009 | 1 | 0.310 |
Why?
|
| DNA, Neoplasm | 3 | 2011 | 23 | 0.310 |
Why?
|
| Carcinoma | 1 | 2009 | 57 | 0.300 |
Why?
|
| Brain Neoplasms | 3 | 2023 | 69 | 0.290 |
Why?
|
| Chondrocytes | 1 | 2009 | 147 | 0.280 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2006 | 32 | 0.270 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 56 | 0.270 |
Why?
|
| Cell Proliferation | 4 | 2021 | 158 | 0.270 |
Why?
|
| Flow Cytometry | 2 | 2019 | 75 | 0.260 |
Why?
|
| Immunohistochemistry | 4 | 2016 | 305 | 0.240 |
Why?
|
| Genes, BRCA1 | 1 | 2005 | 12 | 0.240 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2019 | 18 | 0.230 |
Why?
|
| Myeloid Cells | 2 | 2014 | 9 | 0.220 |
Why?
|
| Gene Expression Profiling | 3 | 2013 | 124 | 0.210 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2021 | 32 | 0.210 |
Why?
|
| Marfan Syndrome | 1 | 2023 | 3 | 0.210 |
Why?
|
| Glioblastoma | 1 | 2023 | 11 | 0.210 |
Why?
|
| Models, Genetic | 5 | 2015 | 24 | 0.200 |
Why?
|
| T-Lymphocytes | 2 | 2013 | 51 | 0.200 |
Why?
|
| Plasmids | 4 | 2006 | 40 | 0.200 |
Why?
|
| Sequence Analysis, DNA | 4 | 2010 | 55 | 0.200 |
Why?
|
| Polymerase Chain Reaction | 3 | 2009 | 109 | 0.200 |
Why?
|
| Chromosomes | 2 | 2012 | 2 | 0.190 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2021 | 2 | 0.190 |
Why?
|
| Chondrogenesis | 1 | 2021 | 32 | 0.180 |
Why?
|
| Proteoglycans | 2 | 2018 | 111 | 0.180 |
Why?
|
| Gene Silencing | 2 | 2019 | 21 | 0.170 |
Why?
|
| Models, Biological | 5 | 2021 | 273 | 0.170 |
Why?
|
| Base Sequence | 4 | 2011 | 94 | 0.170 |
Why?
|
| Cell Line, Tumor | 5 | 2023 | 218 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 107 | 0.160 |
Why?
|
| Molecular Sequence Data | 4 | 2011 | 166 | 0.160 |
Why?
|
| Sensory System Agents | 1 | 2018 | 2 | 0.150 |
Why?
|
| Capsaicin | 1 | 2018 | 8 | 0.150 |
Why?
|
| Sensory Thresholds | 1 | 2018 | 18 | 0.150 |
Why?
|
| Female | 8 | 2018 | 12677 | 0.150 |
Why?
|
| Histones | 3 | 2013 | 25 | 0.150 |
Why?
|
| Down-Regulation | 1 | 2018 | 78 | 0.150 |
Why?
|
| Polycomb-Group Proteins | 2 | 2009 | 3 | 0.150 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 174 | 0.150 |
Why?
|
| Alleles | 3 | 2012 | 173 | 0.140 |
Why?
|
| Cardiac Myosins | 1 | 2016 | 1 | 0.130 |
Why?
|
| HLA-DQ Antigens | 1 | 2016 | 2 | 0.130 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 22 | 0.130 |
Why?
|
| Autoantigens | 1 | 2016 | 21 | 0.130 |
Why?
|
| Citrulline | 1 | 2016 | 4 | 0.130 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 77 | 0.130 |
Why?
|
| Interleukin-17 | 1 | 2016 | 12 | 0.130 |
Why?
|
| Aggrecans | 1 | 2016 | 45 | 0.120 |
Why?
|
| Th17 Cells | 1 | 2016 | 16 | 0.120 |
Why?
|
| Autoantibodies | 1 | 2016 | 61 | 0.120 |
Why?
|
| Epigenomics | 1 | 2015 | 17 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 36 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 343 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 3 | 2016 | 54 | 0.110 |
Why?
|
| Aurora Kinases | 1 | 2013 | 2 | 0.110 |
Why?
|
| Mice, Inbred DBA | 1 | 2013 | 12 | 0.110 |
Why?
|
| Genome-Wide Association Study | 2 | 2012 | 233 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 37 | 0.100 |
Why?
|
| Phosphorylation | 1 | 2013 | 122 | 0.100 |
Why?
|
| Major Histocompatibility Complex | 1 | 2012 | 3 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2013 | 118 | 0.100 |
Why?
|
| Piperazines | 1 | 2013 | 64 | 0.100 |
Why?
|
| Dendritic Cells | 1 | 2012 | 23 | 0.100 |
Why?
|
| Gene Expression | 1 | 2013 | 166 | 0.100 |
Why?
|
| Apoptosis | 1 | 2013 | 172 | 0.100 |
Why?
|
| DNA Primers | 2 | 2009 | 44 | 0.100 |
Why?
|
| Protein Binding | 3 | 2010 | 101 | 0.100 |
Why?
|
| Synovial Fluid | 1 | 2012 | 87 | 0.100 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2011 | 3 | 0.090 |
Why?
|
| Cytosine | 1 | 2011 | 3 | 0.090 |
Why?
|
| Expressed Sequence Tags | 2 | 2009 | 5 | 0.090 |
Why?
|
| Cartilage, Articular | 1 | 2016 | 389 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2009 | 27 | 0.090 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2011 | 7 | 0.090 |
Why?
|
| Recombinant Proteins | 2 | 2009 | 162 | 0.090 |
Why?
|
| Spermatogonia | 1 | 2010 | 1 | 0.090 |
Why?
|
| Genomic Imprinting | 1 | 2010 | 1 | 0.090 |
Why?
|
| RNA, Untranslated | 1 | 2010 | 4 | 0.090 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2010 | 8 | 0.090 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 122 | 0.090 |
Why?
|
| Lymphoma, Follicular | 1 | 2010 | 4 | 0.090 |
Why?
|
| Skin Diseases | 1 | 2011 | 24 | 0.090 |
Why?
|
| Neutrophils | 1 | 2011 | 85 | 0.090 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2010 | 1 | 0.080 |
Why?
|
| Genes, Neoplasm | 1 | 2010 | 1 | 0.080 |
Why?
|
| Astrocytoma | 1 | 2010 | 14 | 0.080 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2010 | 15 | 0.080 |
Why?
|
| Epithelium | 1 | 2010 | 17 | 0.080 |
Why?
|
| Brain Chemistry | 1 | 2010 | 39 | 0.080 |
Why?
|
| Genetic Testing | 1 | 2010 | 45 | 0.080 |
Why?
|
| Antigens, CD19 | 1 | 2009 | 1 | 0.080 |
Why?
|
| Insulin | 1 | 2009 | 75 | 0.080 |
Why?
|
| Trout | 1 | 2009 | 1 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 6b | 1 | 2009 | 1 | 0.080 |
Why?
|
| DNA, Complementary | 1 | 2009 | 23 | 0.080 |
Why?
|
| Gene Amplification | 1 | 2009 | 16 | 0.080 |
Why?
|
| Chickens | 1 | 2009 | 30 | 0.080 |
Why?
|
| Luciferases | 2 | 2005 | 18 | 0.080 |
Why?
|
| Genetic Vectors | 1 | 2009 | 51 | 0.080 |
Why?
|
| Transfection | 2 | 2005 | 104 | 0.070 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2007 | 4 | 0.070 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2007 | 9 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2007 | 45 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2014 | 390 | 0.070 |
Why?
|
| Dinucleoside Phosphates | 1 | 2006 | 2 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2006 | 6 | 0.070 |
Why?
|
| Male | 5 | 2013 | 12453 | 0.070 |
Why?
|
| Sulfites | 3 | 2010 | 4 | 0.060 |
Why?
|
| False Positive Reactions | 1 | 2006 | 31 | 0.060 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2006 | 1 | 0.060 |
Why?
|
| Protein Methyltransferases | 1 | 2006 | 2 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 558 | 0.060 |
Why?
|
| Kinetochores | 1 | 2005 | 1 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2005 | 6 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2005 | 15 | 0.060 |
Why?
|
| Germ-Line Mutation | 1 | 2005 | 14 | 0.060 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 67 | 0.060 |
Why?
|
| In Vitro Techniques | 1 | 2005 | 140 | 0.060 |
Why?
|
| Histone Deacetylases | 1 | 2005 | 7 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2005 | 71 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 401 | 0.060 |
Why?
|
| DNA Modification Methylases | 1 | 2023 | 4 | 0.050 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2023 | 2 | 0.050 |
Why?
|
| DNA Repair Enzymes | 1 | 2023 | 8 | 0.050 |
Why?
|
| Fibrillin-1 | 1 | 2023 | 1 | 0.050 |
Why?
|
| DNA Copy Number Variations | 1 | 2023 | 7 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2023 | 52 | 0.050 |
Why?
|
| Phenotype | 1 | 2023 | 254 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 33 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2005 | 337 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 47 | 0.050 |
Why?
|
| Cell Survival | 1 | 2021 | 103 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2021 | 42 | 0.050 |
Why?
|
| Diterpenes | 1 | 2018 | 4 | 0.040 |
Why?
|
| Hindlimb | 1 | 2018 | 13 | 0.040 |
Why?
|
| Neurotoxins | 1 | 2018 | 10 | 0.040 |
Why?
|
| Ankle | 1 | 2018 | 20 | 0.040 |
Why?
|
| Peptides | 1 | 2018 | 81 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 96 | 0.040 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 92 | 0.040 |
Why?
|
| Cloning, Molecular | 2 | 2010 | 28 | 0.040 |
Why?
|
| Cartilage | 1 | 2018 | 96 | 0.040 |
Why?
|
| Spine | 1 | 2018 | 98 | 0.040 |
Why?
|
| Child | 2 | 2010 | 990 | 0.030 |
Why?
|
| Complex Mixtures | 1 | 2016 | 2 | 0.030 |
Why?
|
| Tissue Extracts | 1 | 2016 | 7 | 0.030 |
Why?
|
| Arginine | 1 | 2016 | 10 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2016 | 18 | 0.030 |
Why?
|
| Epitopes | 1 | 2016 | 33 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 685 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2006 | 40 | 0.030 |
Why?
|
| COS Cells | 2 | 2006 | 33 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2015 | 41 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 15 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2014 | 29 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2014 | 34 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2014 | 37 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 49 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2014 | 55 | 0.030 |
Why?
|
| Genome | 1 | 2012 | 8 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2012 | 32 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2012 | 44 | 0.020 |
Why?
|
| Adult | 2 | 2016 | 6584 | 0.020 |
Why?
|
| 5-Methylcytosine | 1 | 2011 | 4 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2011 | 5 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2011 | 12 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2011 | 17 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 55 | 0.020 |
Why?
|
| Osteoarthritis | 1 | 2016 | 308 | 0.020 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2011 | 2 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2011 | 19 | 0.020 |
Why?
|
| Exons | 1 | 2011 | 28 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2011 | 40 | 0.020 |
Why?
|
| CCCTC-Binding Factor | 1 | 2010 | 1 | 0.020 |
Why?
|
| Methylation | 1 | 2010 | 7 | 0.020 |
Why?
|
| Lysine | 1 | 2010 | 9 | 0.020 |
Why?
|
| Fetus | 1 | 2010 | 23 | 0.020 |
Why?
|
| RNA, Long Noncoding | 1 | 2010 | 5 | 0.020 |
Why?
|
| Heterozygote | 1 | 2011 | 71 | 0.020 |
Why?
|
| Multigene Family | 1 | 2010 | 7 | 0.020 |
Why?
|
| Blast Crisis | 1 | 2010 | 1 | 0.020 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 2 | 0.020 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 3 | 0.020 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2010 | 2 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 5 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2010 | 42 | 0.020 |
Why?
|
| Cytokines | 1 | 2011 | 167 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 11 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2009 | 25 | 0.020 |
Why?
|
| Insulin-Secreting Cells | 1 | 2009 | 11 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 307 | 0.020 |
Why?
|
| Algorithms | 1 | 2011 | 305 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 311 | 0.020 |
Why?
|
| Neurons | 1 | 2010 | 259 | 0.020 |
Why?
|
| Heterochromatin | 1 | 2006 | 1 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2006 | 4 | 0.020 |
Why?
|
| Haploidy | 1 | 2005 | 1 | 0.010 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2005 | 1 | 0.010 |
Why?
|
| Nucleosomes | 1 | 2005 | 2 | 0.010 |
Why?
|
| NIH 3T3 Cells | 1 | 2005 | 2 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 6 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 4 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2005 | 18 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2005 | 32 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 32 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 70 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 131 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 259 | 0.010 |
Why?
|
| Brain | 1 | 2011 | 1324 | 0.010 |
Why?
|
| Middle Aged | 1 | 2011 | 7555 | 0.010 |
Why?
|
| Aged | 1 | 2011 | 7669 | 0.010 |
Why?
|